Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

UBS Warburg Cuts AmerisourceBergen Target

UBS Warburg cut AmerisourceBergen's (ABC) price target by $2 to $68.

Analyst Howard Capek says he thinks Tenet Healthcare has pulled its $450 million a year pharmaceutical distribution contract from AmericsourceBergen, and will begin using McKesson Corp. in early 2003. Capek cited price and service for Tenet's decision. Given the tight structure of typical hospital contracts (price, payment terms, etc.), Capek says he doesn't think this will have material financial impact on AmericsourceBergen.

However, Capek says collapsing a distribution contract with high-need clients highlights the potential risks of integration. He finds the $68 target appropriate for the sector and company-specific risks involved. Capek is keeping his $3.88 fiscal 2003 (Sept.) earnings per share and $4.49 fiscal 2004 estimates. He also rates the shares as hold.

blog comments powered by Disqus